Purchase Order 75N92019P00304
Award Date 7/26/19
Potential Completion Date 7/26/19
Potential Value $224K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $224,400.00 firm fixed price purchase order to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents. The award is for the provision of a NextSeq 550 Sequencing System with a trade-in of a HiSeq 500 system. This award does not have a set-aside designation. Illumina has previously received prime federal contracts from agencies such as the NIH,...
- The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing systems and related products, to provide a NextSeq 2000 sequencing system. The potential value of the contract is $290,700.00. There was no set-aside designation for this award. Illumina has previously received prime contract awards from federal agencies like the National...
- This federal contract award from the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), is a firm fixed price delivery order issued to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The $26,672.00 award is for the provision of Illumina's proprietary sequencing instruments, reagents, and related consumables and services, including NextSeq, NovaSeq, MiSeq, and iSeq platforms, to support genomic research and...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) awarded a $178,500.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of genomic analysis instruments and reagents, for the purchase of a NextSeq 500 sequencing system. This award supports the NIH's research and diagnostic needs, as Illumina has provided a range of sequencing systems and consumables to HHS, the Centers for Disease Control and Prevention, the Department of...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and related products. The contract is for the provision of a NEXTSEQ 1000 SEQUENCING SYSTEM, with a potential value of $142,100.00. The contract does not have a set-aside designation and is expected to be completed by April 14, 2025. Illumina has...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 Sequencing System or equal, valued at $239,700.00. The requirement was issued through a commercial items solicitation using Simplified Acquisition Procedures, with no set-aside designation. The sequencing system is intended to support the increased workload at the Center for Human Immunology,...
- This firm fixed-price delivery order was awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing and analysis equipment. The $148,830.24 contract provides for the delivery of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and...
- The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences awarded a firm fixed price delivery order to Illumina, Inc., a manufacturer of genomic sequencing systems and bioinformatics solutions. The $44,293.79 award does not utilize a set-aside program and is intended to provide the NIH with Illumina's proprietary sequencing instruments, reagents, and related products and services to support genomic analysis research....
- This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $83,122 contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics...
- This is a federal contract award to Illumina, Inc., a manufacturer of genetic sequencing systems and related products, by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH). The $94,636.62 firm fixed-price delivery order contract is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents, consumables, and support services. The contract has no set-aside designation. Illumina...